CYChenxing Yang

Chenxing Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chenxing Yang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Shan Deng

    Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China

    2 shared publications
  • Duqiu Liu

    Clinic Center of Human Gene Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China

    1 shared publication
  • Duqiu Liu

    Cardiovascular Center, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430060, China

    1 shared publication
  • Guochen Li

    Department of Epidemiology, NHC Key Laboratory for Health Technology Assessment, Fudan University School of Public Health, Shanghai 200032, China

    1 shared publication
  • Jingjie Xiong

    Cardiovascular Center, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430060, China

    1 shared publication
  • Jinjie Xiong

    Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China

    1 shared publication

Latest Publications

  • Open Access

    Association Between Sleep Patterns and the Risk of Cardiometabolic Diseases or Cardiometabolic Multimorbidity and the Mediating Role of Metabolic Biomarkers: A Prospective Study of the UK Biobank Cohort

    by Duqiu Liu, Yi Guo, Guochen Li, Chenxing Yang, Jingjie Xiong, Shan Deng, Ru Chen

    Aim: To identify the relationship between joint sleep patterns and the incidence of cardiometabolic diseases (CMDs) and multimorbidity (CMM) as well as the mediating effects of plasma metabolites. Methods: This prospective study included 190,827 participants from the UK Biobank. The joint sleep pattern was evaluated by the healthy sleep score according to five sleep factors (chronotype, sleep duration, insomnia, snoring, and excessive daytime sleepiness). Cox proportional hazards models were utilized to evaluate the relationship between sleep-related metabolites and the incidence of CMM and CMDs. Mediation analyses were conducted to quantify the potential mediating effects of circulating metabolites. Results: After a median follow-up of 13.5 years, 24,602 incident cases of CMDs and 2740 incident cases of CMM were identified. Per 1-decrement of sleep score was associated with 10.5% and 15.1% increased risks of CMDs and CMM, respectively. However, sleep was not associated with the progression from the first disease to CMM. A total of 152 metabolites were identified to be associated with sleep patterns, among which lipoproteins emerged as the predominant class. Most of the metabolites showed mediation effects on the association between sleep and outcomes. Conclusions: Poor sleep pattern was associated with increased risk of CMDs and CMM. Differences in metabolites, especially lipoproteins, might partially explain the association between sleep pattern and cardiometabolic health.

  • Open Access

    Associations Between Physical Capability Markers and Risk of Coronary Artery Disease: A Prospective Study of 439,295 UK Biobank Participants

    by Duqiu Liu, Chenxing Yang, Tianyu Guo, Yi Guo, Jinjie Xiong, Ru Chen, Shan Deng

    Background: The relationship between sarcopenia and the incidence of coronary artery disease (CAD) is not well understood. This study aimed to investigate this relationship and the modifying effect of potential risk factors. Methods: We conducted a prospective study including 439,295 individuals from the UK Biobank. The primary outcome was the incidence of CAD. The main physical capability markers for sarcopenia, grip strength and muscle mass, were investigated as risk factors of interest. Grip strength was measured using a Jamar J00105 (Lafayette, IN, USA) hydraulic hand dynamometer, while muscle mass was estimated through bioelectrical impedance. Cox proportional hazard models were employed to analyze the associations between the exposures and the risk of CAD. Results: A total of 41,564 incident cases of CAD were identified after a median follow-up of 13.15 years (IQR 12.29–13.88 years). Compared with the lowest quintile of grip strength, the adjusted HRs for incidences of CAD from the second to the fifth quintile were 0.81 (95% CI: 0.79–0.83), 0.71 (95% CI: 0.69–0.73), 0.61 (95% CI: 0.60–0.63), and 0.49 (95% CI: 0.48–0.51). The association remained significant in subgroup analysis and interactions were observed between the two exposures and sex, age, smoking status, inflammatory diseases, metabolic syndrome, and genetic predisposition (all p for interactions < 0.05). Conclusions: Physical capability markers of sarcopenia, grip strength and muscle mass, were independently associated with a dose–response decreased risk for CAD incidence, regardless of genetic predisposition and potential modifying risk factors.